BMS-986406
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986406, covering 2024-09-26 to 2024-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors [Phase 1]